March 5th 2025
The partnership will advance the accessibility, scalability, and affordability of RNA-based vaccines.
Pandemic Preparedness Picks Up Pace with First Flu Vaccine Approval
April 22nd 2007The FDA's (Rockville, MD, www.fda.gov) first approval in the United States of a vaccine for humans against the H5N1 influenza virus marks an important step forward in protecting the public against a pandemic influenza outbreak.
From the Editor in Chief: A Shot In The Arm
July 1st 2006The approvals of two groundbreaking vaccines in the last month is encouraging news. Vaccines have long been undervalued because they haven't been as profitable as other pharmaceuticals. So it's good to see them getting deserved attention that goes beyond fears of flu outbreaks.
Final Word: Creative Solutions Can Ensure Pandemic Flu Preparedness
May 1st 2006Certain areas of the vaccine market appear to be in vogue again, revitalized by blockbusters such as Prevnar, the pneumococcal pneumonia vaccine that reaped $1.5 billion in sales last year, and the human papilloma virus vaccines, which are projected to reach $4 billion per year.
Legal Forum: Responding to the Avian Flu Threat: Balancing Risks and Rewards
February 1st 2006Human infections with avian flu strain H5N1 are occurring in a number of southeast Asian countries that have experienced large outbreaks of avian influenza. How great a risk to the human population is posed by this virus, and what steps can be taken to minimize its impact? Preventive vaccines have great potential to avert the spread of avian flu and other infectious diseases. What are the factors affecting the creation of new vaccines, and how can they be optimized to promote public health?